Skip to content

Single Session Narrative Therapy Study

Pilot Study of Feasibility, Acceptability, Fit and Clinical Impact of a Single Session Narrative Psychotherapy Intervention to Reduce Wait Times in a Primary Care HIV Clinic

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06479980
Enrollment
64
Registered
2024-06-28
Start date
2024-06-04
Completion date
2025-05-15
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV, Mental Health Issue, Substance Use

Keywords

Brief narrative therapy, Implementation outcome, Stepped care, Psychotherapy, Integrated primary care

Brief summary

This pilot research study will provide timely access to behavioral health services through the provision of a single-session narrative therapy intervention. The goal of this 6-month study is to test the acceptability, feasibility, and fit of the intervention in an integrated primary care clinic serving people living with HIV.

Detailed description

Single-session interventions are designed to address barriers to engaging in care and address the issues of long waitlists and limited provider availability. Offering a single session intervention soon after a referral is made is a strategy on a stepped-care continuum model that has been found to be an effective approach to manage population mental health needs. This study aims to 1) pre-pilot a single-session narrative therapy intervention with patients currently on the waitlist for psychotherapy services at an HIV primary care clinic to evaluate the acceptability of this treatment option for patients and the feasibility of proposed data collection followed by 2) a 6-month pilot study of the same intervention to evaluate intervention acceptability, fit, and impact on service and clinical outcomes. At the end of this study, patient and provider-level data on the utility of integrating a single-session psychotherapy service as part of the continuum of behavioral health services in an integrated care setting will be obtained, which the investigators can utilize to design a larger implementation-effectiveness trial.

Interventions

Single-session narrative psychotherapy intervention is an evidence-based strategy on a stepped care continuum that can assist patients in accessing care when they most need it and can lead to the most effective utilization of scarce resources. It offers a transdiagnostic, strengths, solution-oriented, and non-pathologizing intervention to address patients' behavioral health needs.

Sponsors

University of Washington
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patient Inclusion Criteria * Adults (age 18 years and older) who are patients at \[Blinded\] Clinic * Have agreed to participate in the single session intervention * Ability to complete the interview and research surveys in English Patient

Exclusion criteria

* Participants with need for urgent mental health treatment (e.g., at imminent risk of suicide or harm to others; disabling symptom presentation) * Inability to provide informed consent Provider Inclusion Criteria: * Adults (age 18 years and older) * Referring providers at \[Blinded\] clinic (social worker, primary care physician, mental health professional etc.) * Ability to complete the research survey or interview in English. Provider

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionnaire-9 (PHQ-9)1 monthThe Patient Health Questionnaire-9 (PHQ-9) is a 9-item validated self-report measure used to screen for depression, diagnose it, monitor its severity, and measure treatment response. The PHQ-9 ranges from 0 to 27 points, with higher scores reflecting more severe symptoms. Scores ≥ 10 indicate moderate depression. This measure was only collected and reported for patient participants.

Secondary

MeasureTime frameDescription
Generalized Anxiety Disorder- 7 (GAD-7)1 monthThe Generalized Anxiety Disorder 7-item (GAD-7) is a validated brief self-report tool that measures anxiety symptoms based on the Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria. The total score ranges from 0 to 21, with higher scores indicating greater severity. Scores ≥ 10 indicate moderate anxiety. This measure was only collected and reported for patient participants.
Remoralization Scale1 monthThe Remoralization Scale is a validated 12-item self-report measure rated on a 4-point scale ranging from 1 ("Totally disagree") to 4 ("Totally agree") that assesses the level of remoralization. The total score ranges from 12 to 48, with higher scores indicating higher levels of remoralization. This measure was only collected and reported for patient participants.
Social Connectedness Scale-Original (SCS-Original)1 monthThe Social Connectedness Scale is an 8-item instrument that assesses the degree to which one feels connected to others in their social environment. Items are measured on a 6-point Likert scale ranging from 1 ("Strongly Agree") to 6 ("Strongly Disagree"). Total scores range from 8 to 48 points. Higher total scores indicate a greater sense of social connectedness. This measure was only collected and reported for patient participants.
State-Trait Assessment of Resilience Scale (Trait Sub-scale Only)1 monthThe State-Trait Assessment of Resilience Scale measures resilience using a state and trait approach, based on the conceptualization of resilience as being influenced by a combination of state and trait factors. This study will only measure the 'Trait' level of resilience, using the trait sub-scale (7-item instrument), which is construed as more distal and enduring. Items are measured on a 4-point Likert scale ranging from 1 ("Disagree") to 4 ("Strongly agree"). Total sum scores are calculated for the sub-scale and range from 7 to 28 points; higher scores reflect greater resilience. This measure was only collected and reported for patient participants.
Brief Services Evaluation1 monthThe Brief Services Evaluation is a 6-item self-report measure assessing patients' perceptions of their skills, ideas, and knowledge related to the primary problem that brought them to counseling. Items are rated on a 6-point Likert scale ranging from 1 ("Strongly disagree") to 6 ("Strongly agree"). Item-level score totals range from 1 to 6. We report item-level changes and significance levels consistent with the Canadian study. The BSE was completed by pilot participants immediately before and one month after their first SSNT session. This measure was only collected and reported for patient participants.
Acceptability of Intervention Measure (AIM)1 Month for patient participants; 0 Month for referring providersThe Acceptability of Intervention Measure is a 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale 1 ("Completely Disagree") to 5 ("Completely Agree"). Score is a calculated mean that ranges from 1-5. Higher mean scores indicating greater perceived intervention acceptability.
Intervention Appropriateness Measure (IAM)0 Month for referring providersThe Intervention Appropriateness Measure is a 4-item measure of perceived intervention appropriateness. Items are measured on a 5-point Likert scale 1 ("Completely Disagree") to 5 ("Completely Agree"). Score is a calculated mean that ranges from 1-5. Higher mean scores indicating greater perceived intervention acceptability.
Feasibility of Intervention Measure (FIM)0 Month for referring providersThe Feasibility of Intervention Measure is a 4-item measure of perceived intervention feasibility. Items are measured on a 5-point Likert scale 1 ("Completely Disagree") to 5 ("Completely Agree"). Score is a calculated mean that ranges from 1-5. Higher mean scores indicating greater perceived intervention feasibility.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAkansha Vaswani-Bye

University of Washington

Participant flow

Recruitment details

51 patients on the waitlist for psychotherapy accepted the SSNT intervention as routine clinic care and received at least one SSNT session. All patients who accepted the SSNT intervention were invited to participate in the research study. Of these, 43 patients provided informed consent and were enrolled in the research study. After patient enrollment and participation were completed, 21 referring providers consented and completed feedback assessments.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
8 Participants
Age, Categorical
Between 18 and 65 years
34 Participants
Brief Services Evaluation
Awareness of strengths to solve the problem
3.93 Score on items
STANDARD_DEVIATION 1.18
Brief Services Evaluation
Ideas to solve the problem
3.57 Score on items
STANDARD_DEVIATION 1.14
Brief Services Evaluation
Knowledge of community resources available to help
3.43 Score on items
STANDARD_DEVIATION 1.14
Brief Services Evaluation
Knowledge of social supports available to help
3.93 Score on items
STANDARD_DEVIATION 1.46
Brief Services Evaluation
Skills needed to solve the problem
3.25 Score on items
STANDARD_DEVIATION 1.35
Brief Services Evaluation
Understanding of the problem
4.71 Score on items
STANDARD_DEVIATION 1.01
Generalized Anxiety Disorder- 7 (GAD-7)6.5 Score on a scale
Patient Health Questionnaire-9 (PHQ-9)8.50 Score on a scale
Race/Ethnicity, Customized
American Indian or Alaskan Native
1 Participants
Race/Ethnicity, Customized
Asian
0 Participants
Race/Ethnicity, Customized
Black or African American
12 Participants
Race/Ethnicity, Customized
Hispanic or Latino
8 Participants
Race/Ethnicity, Customized
More than one race
5 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
32 Participants
Race/Ethnicity, Customized
Pacific Islander
1 Participants
Race/Ethnicity, Customized
Unknown or not reported
6 Participants
Race/Ethnicity, Customized
Unknown or Not Reported
2 Participants
Race/Ethnicity, Customized
White
17 Participants
Remoralization Scale29.33 Score on a scale
STANDARD_DEVIATION 7.88
Sex/Gender, Customized
Demiboy
0 Participants
Sex/Gender, Customized
Female
8 Participants
Sex/Gender, Customized
Gender queer
2 Participants
Sex/Gender, Customized
Male
28 Participants
Sex/Gender, Customized
Nonbinary
2 Participants
Sex/Gender, Customized
Unknown or Not Reported
2 Participants
Social Connectedness Scale-Original (SCS-Original)30.62 Score on a scale
STANDARD_DEVIATION 11.36
State-Trait Assessment of Resilience Scale (Trait sub-scale only)21.79 Score on a scale
STANDARD_DEVIATION 4.16

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 420 / 0
other
Total, other adverse events
0 / 420 / 0
serious
Total, serious adverse events
0 / 420 / 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026